Interactions between Methicillin and Vancomycin in Methicillin-Resistant Staphylococcus aureus Strains Displaying Different Phenotypes of Vancomycin Susceptibility

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Clinical Microbiology

• Publication date

  1999-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/JCM.37.9.3068-3071.1999PMID 10449511PMCID PMC85462
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic control of population structure in heterogeneous strains of methicillin resistantStaphylococcus aureus

  2006cited by this paper
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard

  2000cited by this paper
• Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard

  2000cited by this paper
• First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital.

  1998cited by this paper
• Vancomycin-resistant Staphylococcus aureus.

  1998cited by this paper
• Characterization of Staphylococci with Reduced Susceptibilities to Vancomycin and Other Glycopeptides

  1998influential reference
• Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus

  1997cited by this paper
• Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.

  1997influential reference
• Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

  1997influential reference
• Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.

  1997cited by this paper
• Antibiotics in Laboratory Medicine Edited by Victor Lorian. 4th ed. Baltimore: Williams & Wilkins, 1996. 1,238 pp., illustrated. $189

  1997cited by this paper
• Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications

  1997cited by this paper
• Vancomycin-Resistant Staphylococcus aureus

  1996cited by this paper
• A critical assessment of the agar dilution chequerboard technique for studying in-vitro antimicrobial interactions using a representative beta-lactam, aminoglycoside and fluoroquinolone.

  1995cited by this paper
• Oxacillin-induced inhibition of protein and RNA synthesis in a tolerant Staphylococcus aureus isolate

  1988cited by this paper
• Resistance heterogeneity in methicillin-resistant Staphylococcus aureus

  1984cited by this paper
• National Committee for Clinical Laboratory Standards.

  1980cited by this paper
• [Antimicrobial combinations].

  1972cited by this paper

• Escalation of antimicrobial resistance among MRSA part 2: focus on infections and treatment

  2022cites this paper
• SURVEILLANCE OF CURRENT ANTIBIOTIC RESISTANCE AMONG CLINICAL ISOLATES S. AUREUS, E. COLI AND P. AEROGINOSA COLLECTED FROM FIVE IRANIAN CITIES

  2013cites this paper
• Probing the evolutionary conserved regions within functional site of drug-resistant target proteins of Staphylococcus aureus: In silico phylogenetic motif profiling approach.

  2012cites this paper
• In Vivo Synergism of Ceftobiprole and Vancomycin against Experimental Endocarditis Due to Vancomycin-Intermediate Staphylococcus aureus

  2011influential citation
• Antibiotic sensitivity profile of bacterial pathogens in postoperative wound infections at a tertiary care hospital in Gujarat, India

  2011cites this paper
• The antagonistic effects of a combination of vancomycin and minocycline in Staphylococcus aureus with heterogeneous resistance to vancomycin

  2008cites this paper
• Modified PAP method to detect heteroresistance to vancomycin among methicillin resistant Staphylococcus aureus isolates at a tertiary care hospital.

  2008influential citation
• Detection of Vancomycin Heteroresistant Staphylococcus aureus Using Mu-3 Agar

  2007cites this paper
• Staphylococcus aureus'ta metisilin ve vankomisin direnci

  2007cites this paper
• Interactions between Glycopeptides and β-Lactams against Isogenic Pairs of Teicoplanin-Susceptible and -Resistant Strains of Staphylococcus haemolyticus

  2006cites this paper
• Relationship of Minimal Inhibitory Concentration and Bactericidal Activity to Efficacy of Antibiotics for Treatment of Ventilator-Associated Pneumonia

  2006cites this paper
• ESTUDIO EXPERIMENTAL DE LA EFICACIA DE LOS GLUCOPÉPTIDOS EN MONOTERAPIA O CON β-LACTÁMICOS EN LA INFECCIÓN POR Staphylococcus aureus CON SENSIBILIDAD DISMINUIDA A GLUCOPÉPTIDOS

  2006cites this paper
• Methicillin-Resistant S. aureus Ventilator-Associated Pneumonia: Strategies to Prevent and Treat

  2006cites this paper
• Methicillin-Resistant S. aureus Ventilator-Associated Pneumonia: Strategies to Prevent and Treat.

  2006cites this paper
• Relationship of minimal inhibitory concentration and bactericidal activity to efficacy of antibiotics for treatment of ventilator-associated pneumonia.

  2006cites this paper
• Characterisation of laboratory-generated vancomycin intermediate resistant Staphylococcus aureus strains.

  2006cites this paper
• Antibiotic Pharmacokinetics and Pharmacodynamics: How Can They Be Used to Optimize Therapy in Ventilator-Associated Pneumonia?

  2005cites this paper
• Experimental study on the efficacy of combinations of glycopeptides and beta-lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides.

  2005cites this paper
• Porownanie metod szachownicy i E-testu stosowanych do badania przeciwbakteryjnej aktywnosci zestawien dwoch antybiotykow

  2005cites this paper
• Management of Glycopeptide-Resistant Staphylococcus aureus Infections

  2004cites this paper
• Linezolid Treatment of Skeletal Methicillin-Resistant Staphylococcus aureus Infection

  2004cites this paper
• Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001.

  2003cites this paper
• Vancomycin-resistant Staphylococcus aureus: no apocalypse now.

  2003cites this paper
• Mécanismes et méthodes de détection de la résistance de Staphylococcus aureus aux glycopeptides

  2003cites this paper
• Efficacy of vancomycin-beta-lactam combinations against heterogeneously vancomycin-resistant Staphylococcus aureus (hetero-VRSA).

  2003influential citation
• Investigation of β-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR)

  2003cites this paper
• In vitro efficacy of ciprofloxacin alone and in combination with amoxycillin against Salmonella typhi isolates.

  2003cites this paper
• Laboratory Detection and Investigation of Reduced Susceptibility to Vancomycin in Oxacillin-Resistant Staphylococcus aureus

  2003cites this paper
• The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus.

  2002cites this paper
• Nosocomial Spread of a Staphylococcus capitis Strain with Heteroresistance to Vancomycin in a Neonatal Intensive Care Unit

  2002cites this paper
• Combination Effect of Vancomycin and β-Lactams against a Staphylococcusaureus Strain, Mu3, with Heterogeneous Resistance to Vancomycin

  2001cites this paper
• A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital.

  2001cites this paper
• Emergence, Mechanism, and Clinical Implications of Reduced Glycopeptide Susceptibility in Staphylococcus aureus

  2001cites this paper
• Evaluation of Current Methods for Detection of Staphylococci with Reduced Susceptibility to Glycopeptides

  2001cites this paper
• Recherche des souches de Staphylococcus aureus de sensibilité diminuée aux glycopeptides dans un hôpital universitaire (juin 1999 – février 2000)

  2001cites this paper
• Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know.

  2001cites this paper
• In vivo emergence of subpopulations expressing teicoplanin or vancomycin resistance phenotypes in a glycopeptide-susceptible, methicillin-resistant strain of Staphylococcus aureus.

  2001cites this paper
• The VISA/GISA problem: therapeutic implications.

  2001cites this paper
• Glycopeptide resistance in Staphylococcus aureus.

  2000cites this paper
• Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals.

  2000influential citation
• REVIEW ARTICLE Glycopeptide Resistance in Staphylococcus aureus

  2000cites this paper